Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 432)
Posted On: 05/15/2020 10:27:50 AM
Post# of 153937
Posted By: sunclouds
Re: PTM1 #34098
PTMI
I don’t see your proposal on reduced trial fees for priority access post approval as feasible for the following reasons
1) I don’t think that if approved that CYDY will be able to control distribution to select hospitals that participated in trials for the following reasons
- this would have the wrong kind of optics - promising preference for a life saving drug to hospitals running the trials that leads to approval
- I believe that the government is controlling the distribution of the current standard of care drug and CYDY will need this kind of guidance because it doesn’t have a sales and distribution function for the covid indication (Vyera only has access to HIV in the US)

2) hospitals will not want to reduce their fees for trial participation
- elective surgeries are down so hospital profitability is affected and this revenue is very helpful to hospitals top lines
- there are signed contracts for these trials that would need to be changed and the approval for that at the hospitals will be hard to get

IMO













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site